| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A push–pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses
|
Berzofsky, Jay A.
|
|
2012
|
30 |
29 |
p. 4323-4327
5 p.
|
artikel
|
| 2 |
A review of influenza haemagglutinin receptor binding as it relates to pandemic properties
|
Wilks, Sam
|
|
2012
|
30 |
29 |
p. 4369-4376
8 p.
|
artikel
|
| 3 |
Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine
|
Moffitt, Kristin L.
|
|
2012
|
30 |
29 |
p. 4316-4322
7 p.
|
artikel
|
| 4 |
Clinical development of a Vero cell culture-derived seasonal influenza vaccine
|
Ehrlich, Hartmut J.
|
|
2012
|
30 |
29 |
p. 4377-4386
10 p.
|
artikel
|
| 5 |
Clostridium difficile: Development of a novel candidate vaccine
|
Foglia, Ginamarie
|
|
2012
|
30 |
29 |
p. 4307-4309
3 p.
|
artikel
|
| 6 |
Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer
|
Sims, Robert B.
|
|
2012
|
30 |
29 |
p. 4394-4397
4 p.
|
artikel
|
| 7 |
Diverse microbial exposure – Consequences for vaccine development
|
Björkstén, Bengt
|
|
2012
|
30 |
29 |
p. 4336-4340
5 p.
|
artikel
|
| 8 |
Editorial
|
Alkan, Sefik S.
|
|
2012
|
30 |
29 |
p. 4299-4300
2 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2012
|
30 |
29 |
p. CO2-
1 p.
|
artikel
|
| 10 |
Flaviviruses and flavivirus vaccines
|
Heinz, Franz X.
|
|
2012
|
30 |
29 |
p. 4301-4306
6 p.
|
artikel
|
| 11 |
High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge
|
Picard, Michele D.
|
|
2012
|
30 |
29 |
p. 4387-4393
7 p.
|
artikel
|
| 12 |
HIV vaccine development: Challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem
|
Koff, Wayne C.
|
|
2012
|
30 |
29 |
p. 4310-4315
6 p.
|
artikel
|
| 13 |
Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis
|
Poljak, Albina
|
|
2012
|
30 |
29 |
p. 4398-4406
9 p.
|
artikel
|
| 14 |
Intradermal immunization using coated microneedles containing an immunoadjuvant
|
Andrianov, Alexander K.
|
|
2012
|
30 |
29 |
p. 4355-4360
6 p.
|
artikel
|
| 15 |
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives
|
Linhart, Birgit
|
|
2012
|
30 |
29 |
p. 4328-4335
8 p.
|
artikel
|
| 16 |
Nasal and skin delivery of IC31®-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes
|
Wizel, Benjamin
|
|
2012
|
30 |
29 |
p. 4361-4368
8 p.
|
artikel
|
| 17 |
The mechanism of action of MF59 – An innately attractive adjuvant formulation
|
O’Hagan, D.T.
|
|
2012
|
30 |
29 |
p. 4341-4348
8 p.
|
artikel
|
| 18 |
Transcutaneous immunization with Intercell's vaccine delivery system
|
Seid Jr., Robert C.
|
|
2012
|
30 |
29 |
p. 4349-4354
6 p.
|
artikel
|
Tijdschrift beschrijving